Literature DB >> 1672816

Restriction fragment length polymorphism of the tumor necrosis factor region in patients with ankylosing spondylitis.

G M Verjans1, S M van der Linden, G J van Eys, L P de Waal, A Kijlstra.   

Abstract

Although ankylosing spondylitis (AS) is known to be strongly associated with the class I major histocompatibility complex antigen HLA-B27, B27 is probably not the only genetic factor involved in the pathogenesis of AS. Because of the involvement of tumor necrosis factor (TNF) in cartilage damage and the localization of the TNF genes in the proximity of the HLA-B locus, we investigated the association between AS and TNF alleles. The frequencies of the restriction fragment length polymorphisms linked to the TNF genes were determined in 73 AS patients and 81 controls. No differences were observed between AS patients and controls with respect to the frequencies of the TNF restriction fragment length polymorphisms.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1672816     DOI: 10.1002/art.1780340414

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  4 in total

Review 1.  The association of polymorphisms in TNF and ankylosing spondylitis in common population: a meta-analysis.

Authors:  Huae Shu; Hongsheng Sun; Naiwen Hu; Xi Chen; Shanjuan Wang; Gangying Yuan; Qinqin Wang
Journal:  Eur Spine J       Date:  2021-04-20       Impact factor: 3.134

2.  Polymorphism of tumour necrosis factor-alpha (TNF-alpha) at position -308 in relation to ankylosing spondylitis.

Authors:  G M Verjans; B M Brinkman; C E Van Doornik; A Kijlstra; C L Verweij
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

3.  Vitamin D and Tumor Necrosis Factor-Alpha Receptor Gene Polymorphisms in Various Hepatitis B Clinical Conditions in Turkey.

Authors:  Semra Tuncbilek; Kemalettin Aydin; Kenan Hizel
Journal:  Gastroenterology Res       Date:  2013-10-31

4.  TNFB gene polymorphism in patients with systemic lupus erythematosus in Korean.

Authors:  H Y Kim; S H Lee; H I Yang; S H Park; C S Cho; T G Kim; H Han; D J Kim
Journal:  Korean J Intern Med       Date:  1995-07       Impact factor: 2.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.